Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Modified anti-CD3 therapy in psoriatic arthritis: a phase I/II clinical trial.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Modified anti-CD3 therapy in psoriatic arthritis: a phase I/II clinical trial.
Modified anti-CD3 therapy in psoriatic arthritis: a phase I/II clinical trial. J Rheumatol. 2002 Sep; 29(9):1907-13.
View in:
PubMed
subject areas
Adolescent
Adult
Aged
Arthritis, Psoriatic
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Follow-Up Studies
Humans
Male
Maximum Tolerated Dose
Middle Aged
Muromonab-CD3
Pain Measurement
Severity of Illness Index
Treatment Outcome
authors with profiles
Tammy Utset
Maria-Luisa Alegre